{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:51:01Z","timestamp":1745491861059},"reference-count":15,"publisher":"Media Sphere Publishing Group","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2019]]},"DOI":"10.17116\/jnevro201911910151","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:17:03Z","timestamp":1575281823000},"page":"51","source":"Crossref","is-referenced-by-count":5,"title":["Reduction of plasma procoagulant activity in patients with schizophrenia during pharmacotherapy: thrombodynamic parameters of coagulation before and after treatment"],"prefix":"10.17116","volume":"119","author":[{"given":"O. S.","family":"Brusov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Karpova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. I.","family":"Faktor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Sizov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Oleichik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro201911910151-1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201811810153"},{"key":"key-10.17116\/jnevro201911910151-2","doi-asserted-by":"crossref","unstructured":"Kato TA, Monji A, Mizoguchi Y, Hashioka S, Horikawa H, Seki Y, Kasai M, Utsumi H, Kanba S. Anti-ibflammatory properties of antipsychotics via microglia modulation: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? Mini Reviews in Medical Chemistry. 2011;11:565-574.","DOI":"10.2174\/138955711795906941"},{"key":"key-10.17116\/jnevro201911910151-3","unstructured":"The use of the thrombodynamics test, to assess the condition of hemostasis system. Teaching guidelines. 2015. Under the Editorship of Shulutko A.M. 2015. (In Russ.)"},{"key":"key-10.17116\/jnevro201911910151-4","doi-asserted-by":"crossref","unstructured":"Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57-69.","DOI":"10.1038\/nrn2038"},{"key":"key-10.17116\/jnevro201911910151-5","doi-asserted-by":"crossref","unstructured":"McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia. 1993;7(1):84-92.","DOI":"10.1002\/glia.440070114"},{"key":"key-10.17116\/jnevro201911910151-6","doi-asserted-by":"crossref","unstructured":"Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49(1-2):1-52.","DOI":"10.1016\/S0920-9964(01)00163-3"},{"key":"key-10.17116\/jnevro201911910151-7","doi-asserted-by":"crossref","unstructured":"Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry. 2007;64(5):521-529.","DOI":"10.1001\/archpsyc.64.5.521"},{"key":"key-10.17116\/jnevro201911910151-8","doi-asserted-by":"crossref","unstructured":"Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Moller HJ, Klauss V, Schwarz MJ, Riedel M. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010;121(1-3):118-124.","DOI":"10.1016\/j.schres.2010.04.015"},{"key":"key-10.17116\/jnevro201911910151-9","doi-asserted-by":"crossref","unstructured":"Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol. 2008;31(5):287-292.","DOI":"10.1097\/WNF.0b013e3181593d45"},{"key":"key-10.17116\/jnevro201911910151-10","doi-asserted-by":"crossref","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.","DOI":"10.1056\/NEJMoa051688"},{"key":"key-10.17116\/jnevro201911910151-11","doi-asserted-by":"publisher","DOI":"10.1016\/j.sehres.2011.03.019"},{"key":"key-10.17116\/jnevro201911910151-12","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-019-09860-3"},{"key":"key-10.17116\/jnevro201911910151-13","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201711711191-100"},{"key":"key-10.17116\/jnevro201911910151-14","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2016.1155748"},{"key":"key-10.17116\/jnevro201911910151-15","doi-asserted-by":"crossref","unstructured":"Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scandinavian J of immunity. 2007;66:159-165.","DOI":"10.1111\/j.1365-3083.2007.01984.x"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:17:50Z","timestamp":1575281870000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2019\/10\/1199772982019101051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"alternative-id":["jnevro201911910151"],"URL":"https:\/\/doi.org\/10.17116\/jnevro201911910151","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}